$SRNE News Article - Sorrento Announces Full Enrollment of Phase I Study of Intranasal STI-9199 (COVISHIELD(TM) IN), a Potent Neutralization Antibody Against Omicron BA.2 and All Variants of Concern
https://marketwirenews.com/news-releases/sorr...58540.html